YOLFTbeta
Vogenx Inc Common Stock

Vogenx Inc Common Stock

VOGX · NASDAQ · Healthcare / Biotechnology

16.67USD-2.48 (-12.95%)

Price History

Full chart

Market Stats

Previous Close19.15
Open18.22
Day Range16.18 – 19.25
52-Week Range12.95 – 38.41
Volume93.75K
Market Cap337.66M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.12
Dividend Yield0.00%
50-Day Avg28.25
200-Day Avg28.25

About

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. James Green
  • Employees4
  • Headquarters3901 Barrett Drive, Raleigh, NC, United States, 27609, USA
  • Websitehttps://vogenx.com

Leadership

  • Mr. James GreenPresident, CEO & Chairman · b. 1969
  • Mr. Steven R. DelmarCFO, Corporate Secretary & Director · b. 1956
  • Dr. William Wilkison Ph.D.Chief Scientific Officer, Chair of Scientific Advisory Board & Director · b. 1960

Financials

Income Statement

Currency: USD2024-12-312025-12-31
Total Revenue00
Operating Income-2.30M-1.44M
EBITDA-2.30M-1.44M
Net Income-2.20M-1.45M
R&D1.32M571.97K

Balance Sheet

Currency: USD2024-12-312025-12-31
Total Assets970.40K681.17K
Total Liabilities460.81K1.60M
Total Equity509.58K-919.24K
Cash962.92K601.01K
Net Debt-215.29K

Cash Flow

Currency: USD2024-12-312025-12-31
Operating Cash Flow-2.34M-1.11M
Financing Cash Flow0750.00K
Capital Expenditure00
Free Cash Flow-2.34M-1.11M
FCF to OCF100.00%100.00%

Earnings

Report DateSep 17, 2026
EPS Estimate-0.04
EPS Actual-0.07
Surprise-75.00%
Timing-

Key Statistics & Ratios

Market Cap337.66M
Enterprise Value386.91M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.00
EPS-0.12
Book Value-0.338
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding14.86M
Shares Float9.81M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
12.98%
Insiders
4.74%
Retail / Other
82.28%

Top Fund Holders

  • Vanguard Russell 2000 ETF
    5.26K0.04%
  • Vanguard Russell 2000 Growth ETF
    5210.00%
  • Vanguard Russell 2000 Value ETF
    1960.00%
  • Vanguard Russell 3000 ETF
    810.00%